Drug
Rosuvastatin 20 Mg Oral Tablet
Rosuvastatin 20 Mg Oral Tablet is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
20%
Ph phase_3
3
60%
Ph not_applicable
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
3(60.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(1)
Other(1)
Detailed Status
Not yet recruiting2
unknown1
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (20.0%)
Phase 33 (60.0%)
N/A1 (20.0%)
Trials by Status
unknown120%
completed120%
recruiting120%
not_yet_recruiting240%
Recent Activity
1 active trials
Showing 5 of 5
not_yet_recruitingphase_3
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients
NCT07736313
recruitingphase_3
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
NCT07232069
not_yet_recruitingphase_2
Neuroprotection of Memantine and Rosuvastatin
NCT07504198
unknownphase_3
Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis
NCT05731596
completednot_applicable
Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome
NCT05306990
Clinical Trials (5)
Showing 5 of 5 trials
NCT07736313Phase 3
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients
NCT07232069Phase 3
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
NCT07504198Phase 2
Neuroprotection of Memantine and Rosuvastatin
NCT05731596Phase 3
Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis
NCT05306990Not Applicable
Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5